ID,Startzeit,,Fertigstellungszeit,E-Mail,Name,title,doi,eligiblity,exclusion_reason,exclusion_details,study_design,study_design_other,functional_outcome,neurological_condition,effect_estimate,roc_present,covariate_intent,figure_other,figure_other_outcome,spbg_present,figure_identification_1,figure_outcome_1,stratified_1,unadjusted_1,adjusted_1,adjustment_method_1,problems_1,additional_spbg_1,figure_identification_2,figure_outcome_2,stratified_2,unadjusted_2,adjusted_2,adjustment_method_2,problems_2,additional_spbg_2,figure_identification_3,figure_outcome_3,stratified_3,unadjusted_3,adjusted_3,adjustment_method_3,problems_3,additional_spbg_3,figure_identification_4,figure_outcome_4,stratified_4,unadjusted_4,adjusted_4,adjustment_method_4,problems_4,additional_spbg_4,figure_identification_5,figure_outcome_5,stratified_5,unadjusted_5,adjusted_5,adjustment_method_5,problems_5,additional_spbg_5,abstraction_notes
Consensus,all,,DC,1,1,Impact of Prior Antiplatelet Therapy on Outcomes  After Endovascular Therapy for Acute Stroke,10.1161/STROKEAHA.121.034670,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,No,Yes,Regression;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,1,2,Association Between Increased Seizures During Rewarming After Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy and Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up,10.1001/jamaneurol.2021.3723,Yes,,,nested cohort,NA,Bayley Scales of Infant Development III; Gross Motor Function Classification System (GMFCS);,Neonatal hypoxic ischemic encephalopathy;,Risk ratio,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,1,3,Predictors of Long-Term Outcome ofSubthalamic Stimulation in ParkinsonDisease,10.1002/ana.25994,Yes,,,cohort,NA,UPDRS (composite);UPDRS-III;,Parkinson's disease;,Beta coefficient(s) only,Neither;,No,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,1,4,Computed Tomography Perfusion Deficit Volumes  Predict Functional Outcome in Patients With  Basilar Artery Occlusion,10.1161/STROKEAHA.120.032924,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,AUC;ROC;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,1,5,Stroke Care in the United Kingdom During the COVID-19 Pandemic,10.1161/STROKEAHA.120.032253,Yes,,,cohort,NA,mRS;,Stroke (all);,Comparison of values between exposure status with p-value,Neither;,No,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,2,1,Long-Term Evolution of Functional Limitations  in Stroke Survivors Compared With Stroke-Free  Controls: Findings From 15 Years of Follow-Up  Across 3 International Surveys of Aging,10.1161/STROKEAHA.121.034534,Yes,,,cohort,NA,mRS,Stroke (all);,Mean difference,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,2,2,Current Status of Endovascular Treatment for  Acute Large Vessel Occlusion in China A Real-World Nationwide Registry,10.1161/STROKEAHA.120.031869,Yes,,,cohort,NA,mRS,Ischemic stroke;,Odds ratio,Neither;,Yes,Yes,mRS,Yes,Figure 2,mRS,No,Yes,No,NA,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,2,3,Defining a Target Population to Effectively Test a  Neuroprotective Drug,10.1161/STROKEAHA.120.032025,Yes,,,cohort,NA,NIHSS;,Ischemic stroke;,Beta coefficient(s) only,Neither;,Yes,Yes,NIHSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,2,4,Impact of Initial Imaging Protocol on Likelihood of  Endovascular Stroke Therapy,10.1161/STROKEAHA.120.030122,Yes,,,cohort,NA,mRS,Ischemic stroke,Odds ratio,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,2,5,Hematoma Expansion and Clinical Outcomes  in Patients With Factor-Xa Inhibitor–Related  Atraumatic Intracerebral Hemorrhage Treated Within  the ANNEXA-4 Trial Versus Real-World Usual Care,10.1161/STROKEAHA.121.034572,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio; risk ratio; mean difference,Neither;,Yes,Yes,mRS,Yes,Figure 2B top,mRS,No,Yes,No,NA,,Yes,Figure 2B bottom,mRS,No,No,Yes,IPTW;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,3,1,Relation Between the Corticospinal Tract State  and Activities of Daily Living in Patients With Intracerebral Hemorrhage,10.1161/STROKEAHA.121.034939,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,3,2,"Frequency, Determinants, and Outcomes of Emboli to Distal and New Territories Related to Mechanical Thrombectomy for Acute Ischemic Stroke",10.1161/STROKEAHA.120.033377,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,3,3,Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis,10.1001/jamaneurol.2020.2453,Yes,,,cohort,NA,EDSS;MSSS;,Multiple sclerosis;,Hazard ratio,Neither;,Yes,Yes,"EDSS, MSSS",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,3,4,Reduction  in  Cerebrospinal  Fluid  Volume  as  an    Early  Quantitative  Biomarker  of  Cerebral  Edema    After  Ischemic  Stroke,10.1161/STROKEAHA.119.027895,Yes,,,cohort,NA,NIHSS;mRS,Ischemic stroke;,Odds ratio,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,all,,DC,3,5,Predicting 90-Day Outcome After Thrombectomy,10.1161/STROKEAHA.120.032487,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,all,,DC,4,1,Vertebrobasilar Artery Calcification and Outcomes in Posterior Circulation Large Vessel Occlusion Thrombectomy,10.1161/STROKEAHA.119.027958,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure D,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Conensus:,all,,DC,4,2,Characterizing Diaschisis-Related Thalamic  Perfusion and Diffusion After Middle Cerebral  Artery Infarction,10.1161/STROKEAHA.120.032464,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,all,,DC,4,3,Brain Atrophy and the Risk of Futile Endovascular Reperfusion in Acute Ischemic Stroke,10.1161/STROKEAHA.119.028511,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,all,,DC,4,4,"Association of Pediatric ASPECTS and NIH Stroke Scale, Hemorrhagic Transformation, and 12-Month Outcome in Children With Acute Ischemic Stroke",10.1212/WNL.0000000000012558,Yes,,,cohort,NA,PedNIHSS; PSOM;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"PedNIHSS, PSOM",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,all,,DC,4,5,Redefining Hematoma Expansion With the Inclusion of Intraventricular Hemorrhage Growth,10.1161/STROKEAHA.119.027451,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,all,,DC,4,6,Endovascular Treatment for Posterior Circulation Stroke in Routine Clinical Practice: Results of  the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands Registry,10.1161/STROKEAHA.121.034786,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,all,,DC,4,7,"Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy",10.1212/WNL.0000000000009848,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,all,,DC,4,8,Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study,10.1016/S1474-4422(20)30067-3,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Mean difference;Hazard ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,all,,DC,4,9,Mechanical Thrombectomy in Ischemic Stroke Patients with Pre- stroke Disability,10.1161/STROKEAHA.119.028246,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,all,,DC,4,10,Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson’s disease,10.1016/j.brs.2020.09.019,Yes,,,cohort,NA,UPDRS-III;,Parkinson's disease;,Number needed to treat;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,1,Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke,10.1212/WNL.0000000000011598,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 4 (top),mRS,Yes,No,Yes,Stratified (select this if you previously indicated that the graph is stratified);Regression;,,Yes,Figure 4 (bottom),mRS,Yes,No,Yes,Stratified (select this if you previously indicated that the graph is stratified);Regression;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,2,Association of Infarct Volume Before Hemicraniectomy and Outcome After Malignant Infarction,10.1212/WNL.0000000000011987,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,3,Clinical  Outcome  of  Patients  With  Large  Vessel  Occlusion   and  Low  National  Institutes  of  Health  Stroke  Scale  Scores Subanalysis  of  the  RESCUE-Japan  Registry  3,10.1161/STROKEAHA.119.028562,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,No,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,4,Clinical imaging factors of excellent  outcome after thrombolysis in large- vessel stroke: a THRACE  subgroup analysis,10.1136/svn-2020-000852,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,5,Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years,10.1212/WNL.0000000000011242,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,6,"Hypertension, Antihypertensive Use and the Delayed-Onset of Huntington’s Disease",10.1002/mds.27976,Yes,,,cohort,NA,Total motor scale (TMS); total functional capacity (TFC);,Huntington’s disease;,Mean difference;,Neither;,Yes,Yes,UHDRS TFC,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,7,Immediate and Long-Term Outcomes of  Reperfusion Therapy in Patients With Cancer,10.1161/STROKEAHA.120.032380,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,8,Impact  of  Body  Temperature  Before  and  After  Endovascular   Thrombectomy  for  Large  Vessel  Occlusion  Stroke,10.1161/STROKEAHA.119.028160,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 1,mRS,No,Yes,No,NA;,,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,9,Impact of Age and Alberta Stroke Program  Early Computed Tomography Score 0 to 5 on  Mechanical Thrombectomy Outcomes Analysis From the STRATIS Registry,10.1161/STROKEAHA.120.032430,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 2A,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,10,Long-term safety and effectiveness of natalizumab  treatment in clinical practice: 10 years of real-world  data from the Tysabri Observational Program (TOP),10.1136/jnnp-2019-322326,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,11,Off-­hour­effect­is­not­significant­in­ endovascular­treatment­for­anterior­ circulation­large­vessel­occlusion­in­a­ multicentre­registry,10.1136/svn-2021-000949,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2A,mRS,No,Yes,No,NA;,,Yes,Figure 2B,mRS,No,Yes,No,NA;,,Yes,Figure 2C,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,12,Predicting Recovery and Outcome after Pediatric Stroke: Results from the International Pediatric Stroke Study,10.1002/ana.25718,Yes,,,cohort,NA,Pediatric Stroke Outcome Measure (PSOM);,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,PSOM,Yes,Figure 2B,PSOM,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,Yes,Figure 2C,PSOM,No,Yes,No,NA;,Yes,Yes,Figure 3b,PSOM,No,Yes,No,NA;,,Yes,Figure 3c,PSOM,No,Yes,No,NA;,,Yes,Figure 4,PSOM,No,Yes,No,NA;,,,
Consensus:,emma,,DC,5,13,Prognosis of Intracerebral Hemorrhage Related  to Antithrombotic Use An Observational Study From the Swedish Stroke Register (Riksstroke),10.1161/STROKEAHA.120.030930,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,14,Reperfusion Treatment and Stroke Outcomes in Hospitals With Telestroke Capacity,10.1001/jamaneurol.2021.0023,No,wrong outcome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,15,Risks  of  Stroke  and  Mortality  in  Atrial  Fibrillation    Patients Treated With Rivaroxaban and Warfarin,10.1161/STROKEAHA.119.025554,Yes,,,cohort,NA,NIHSS;,Ischemic stroke;,Hazard ratio;,Neither;,Yes,Yes,NIHSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,16,sTWEAK is a marker of early  haematoma growth and leukoaraiosis in  intracerebral haemorrhage,10.1136/svn-2020-000684,Yes,,,cohort,NA,mRS,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,17,Sudden  Recanalization A  Game-Changing  Factor  in  Endovascular  Treatment    of  Large  Vessel  Occlusion  Strokes,10.1161/STROKEAHA.119.028787,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 1A,mRS,No,Yes,No,NA;,,Yes,Figure 1B,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,18,The Effects of Collateral Status on Infarct Distribution Following  Endovascular Therapy in Large Vessel Occlusion Stroke,10.1161/STROKEAHA.120.029892,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,19,Thrombus NET content is associated with clinical outcome in stroke and myocardial infarction,10.1212/WNL.0000000000009532,Yes,,,cohort,NA,mRS;,Ischemic stroke;acute myocardial infarction (AMI);,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 4B,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,5,20,Acute  Neurological  Deterioration  in  Large  Vessel  Occlusions   and  Mild  Symptoms  Managed  Medically,10.1161/STROKEAHA.119.027011,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,5,1,Acute symptomatic seizures in cerebral venous thrombosis,10.1212/WNL.0000000000010577,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 3,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,5,2,Association of Serum IL-6 (Interleukin 6) With Functional Outcome After Intracerebral Hemorrhage,10.1161/STROKEAHA.120.032888,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,5,3,Association of specific biotypes in patients with Parkinson disease and disease progression,10.1212/WNL.0000000000010498,Yes,,,cohort,,UPDRS; UPDRS-III,Parkinson's disease;,Beta coefficient(s) only;,Neither,Yes,Yes,"UPDRS, UPDRS-III",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,5,4,Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis,10.1212/NXI.0000000000000974,Yes,,,cohort,NA,mRS;,Encephalitis;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,5,5,Clinical effectiveness of different natalizumab interval  dosing schedules in a large Italian population of  patients with multiple sclerosis,10.1136/jnnp-2020-323472,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,5,6,Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial,10.1212/WNL.0000000000010024,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,5,7,Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders,10.1136/jnnp-2021-327206,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,5,8,Fixed Compared With Autoregulation-Oriented Blood Pressure Thresholds After Mechanical Thrombectomy for Ischemic Stroke,10.1161/STROKEAHA.119.026596,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,5,9,Impact of COVID-19 Infection on the Outcome of  Patients With Ischemic Stroke,10.1161/STROKEAHA.121.034883,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 1,mRS,,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,5,10,Impact of Periprocedural and Technical Factors and Patient Characteristics on Revascularization and Outcome in the DAWN Trial,10.1161/STROKEAHA.119.026437,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,5,1,Association of Venous Outflow Profiles and Successful Vessel Reperfusion After Thrombectomy,10.1212/WNL.0000000000012106,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,5,2,Distributional Validity and Prognostic Power of the National Institutes of Health Stroke Scale in US Administrative Claims Data,10.1001/jamaneurol.2019.5061,Yes,,,cross-sectional,NA,NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,NIHSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,5,3,Early Recanalization in Patients With Cerebral Venous Thrombosis Treated With Anticoagulation Diana,10.1161/STROKEAHA.119.028532,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,5,4,Haptoglobin genotype and outcome after aneurysmal subarachnoid haemorrhage,10.1136/jnnp-2019-321697,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,No,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,5,5,Impact of Preexisting Cognitive Impairment and Race/Ethnicity on Functional Outcomes Following Intracerebral Hemorrhage,10.1161/STROKEAHA.120.030084,Yes,,,case-control,NA,mRS;Barthel Index;,Hemorrhagic stroke;,Odds ratio;Comparison of values between exposure status with p-value;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,5,6,Liver  Fibrosis  Indices  and  Outcomes  After  Primary   Intracerebral  Hemorrhage,10.1161/STROKEAHA.119.028161,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,5,7,Multiple hypointense vessels on  susceptibility-weighted imaging predict early neurological deterioration in acute ischaemic stroke patients with severe intracranial large artery stenosis or occlusion receiving  intravenous thrombolysiS,10.1136/svn-2020-000343,Yes,,,cohort,NA,NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,5,8,Reversible Ischemic Lesion Hypodensity in Acute Stroke CT Following Endovascular Reperfusion,10.1212/WNL.0000000000012484,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 3,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,5,9,Trends in Reperfusion Therapy for In-Hospital Ischemic Stroke in the Endovascular Therapy Era,10.1001/jamaneurol.2020.3362,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,5,10,Mean platelet volume and its genetic variants relate to stroke severity and 1-year mortality,10.1212/WNL.0000000000010105,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2B,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,1,Association between fluid-attenuated  inversion recovery vascular  hyperintensity and outcome varies with  different lesion patterns in patients with  intravenous thrombolysis,10.1136/svn-2020-000641,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,2,Association of the Level of Neurofilament Light With Disease Severity in Patients With Spinocerebellar Ataxia Type 3,10.1212/WNL.0000000000012945,Yes,,,cross-sectional,NA,SARA;ICARS;INAS;,spinocerebellar ataxia type 2 (SCA2);,pearson correlation r;,Neither;,Yes,No,"SARA,INAS,ICARS",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,3,Blood  Pressure  Variability  and  Neurologic  Outcome    After Endovascular Thrombectomy A  Secondary  Analysis  of  the  BEST  Study,10.1161/STROKEAHA.119.027549,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,4,Blood Pressure Goals and Clinical Outcomes after Successful Endovascular Therapy: A Multicenter Study,10.1002/ana.25716,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS,NIHSS",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,5,Characterization of Subarachnoid Hyperdensities After Thrombectomy for Acute Stroke Using Dual-Energy CT,10.1212/WNL.0000000000013198,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 3A,mRS,No,Yes,No,NA;,,Yes,Figure 3B,mRS,No,Yes,No,NA;,,Yes,Figure 3C,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,6,Computed  Tomography  Perfusion  Identifies  Patients  With   Stroke  With  Impaired  Cardiac  Function,10.1161/STROKEAHA.119.027255,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,No,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,7,Cortical involvement determines impairment 30 years after a clinically isolated syndrome,10.1093/brain/awab033,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Beta coefficient(s) only;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,8,Disease Progression in Patients with Parkin-Related Parkinson’s Disease in a Longitudinal Cohort,10.1002/mds.28349,Yes,,,cohort,NA,UPDRS-III;,Parkinson's disease;,partial correlation r;,Neither;,Yes,Yes,UPDRS III,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,9,Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis,10.1212/NXI.0000000000000979,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Beta coefficient(s) only;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,10,Female Stroke Sex Differences in Acute Treatment and Early Outcomes of Acute Ischemic  Stroke,10.1161/STROKEAHA.120.032850,Yes,,,cohort,NA,RS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,RS,Yes,Figure 1,RS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,11,Imaging Predictors of Neurologic Outcome After Pediatric Arterial Ischemic Stroke,10.1161/STROKEAHA.120.030965,Yes,,,cohort,NA,PSOM;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,PSOM,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,12,Initial Stroke Severity in Patients With Atrial  Fibrillation According to Antithrombotic Therapy  Before Ischemic Stroke,10.1161/STROKEAHA.120.030138,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,13,Late onset depression: dopaminergic deficit and  clinical features of prodromal Parkinson’s disease: a  cross-sectional study,10.1136/jnnp-2020-324266,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,14,Prognostic value of systemic immune– inflammation index in acute/subacute  patients with cerebral venous  sinus thrombosis,10.1136/svn-2020-000362,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,AUC;ROC;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,15,Risk of Distal Embolization From tPA (Tissue-Type  Plasminogen Activator) Administration Prior to  Endovascular Stroke Treatment,10.1161/STROKEAHA.120.029025,Yes,,,cohort,NA,mRS;mNIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,16,"Risk, Clinical Course, and Outcome of Ischemic  Stroke in Patients Hospitalized With COVID-19 A Multicenter Cohort Study",10.1161/STROKEAHA.121.034787,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,17,Role of S100B Serum Concentration as a Surrogate Outcome Parameter After Mechanical Thrombectomy,10.1212/WNL.0000000000012918,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,No,Yes,mRS,Yes,Figure 2,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,18,Thrombectomy for Primary Distal Posterior Cerebral Artery Occlusion Stroke The TOPMOST Study,10.1001/jamaneurol.2021.0001,Yes,,,case-control,NA,mRS;NIHSS;,Ischemic stroke;,Comparison of values between exposure status with p-value; Mean difference;,Neither;,Yes,Yes,NIHSS,Yes,Figure 3,mRS,No,No,Yes,PS Matching;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,19,Two-year regional grey and white matter volume  changes with natalizumab and fingolimod,10.1136/jnnp-2019-322439,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,emma,,DC,6,20,"Values of Baseline Posterior Circulation Acute  Stroke Prognosis Early Computed Tomography  Score for Treatment Decision of Acute Basilar  Artery Occlusion Hongfei Sang , MD*; Fengli Li , MD*; Junjie Yuan",10.1161/STROKEAHA.120.031371,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;Risk ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 1,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,6,1,CTA-for-All: Impact of Emergency Computed Tomographic Angiography for All Patients With Stroke Presenting Within 24 Hours of Onset,10.1161/STROKEAHA.119.027356,Yes,,,cohort,NA,GOS;,Ischemic stroke;,Risk ratio; Odds ratio;,Neither;,Yes,Yes,GOS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,6,2,Different Predictive Factors for Early Neurological Deterioration Based on the Location of Single Subcortical Infarction: Early Prognosis in Single Subcortical Infarction,10.1161/STROKEAHA.120.032966,Yes,,,cohort,NA,NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,6,3,Effect of Moderate and Severe Persistent Hyperglycemia on Outcomes in Patients With Intracerebral Hemorrhage,10.1161/STROKEAHA.121.034928,Yes,,,cohort,NA,mRS; NIHSS,Hemorrhagic stroke;,Odds ratio;,AUC;,Yes,No,NA,Yes,Figure 2,mRS,Yes,Yes,No,Stratified,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,6,4,Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage,10.1136/jnnp-2019-321774,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,6,5,"Impact of Statins on Hematoma, Edema, Seizures, Vascular Events, and Functional Recovery After Intracerebral Hemorrhage",10.1161/STROKEAHA.120.029345,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,6,6,Longitudinal Changes in Parkinson's Disease Symptoms with and Without Rapid Eye Movement Sleep Behavior Disorder: The Oxford Discovery Cohort Study,10.1002/mds.28763,Yes,,,cohort,NA,UPDRS-III;,Parkinson's disease;,Beta coefficient(s) only;,Neither,Yes,Yes,UPDRS-III,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,6,7,Neutrophil-to-Lymphocyte Ratio Predicts Cerebral Edema and Clinical Worsening Early After Reperfusion Therapy in Stroke,10.1161/STROKEAHA.120.032130,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,6,8,Relation of Pre-Stroke Aspirin Use With Cerebral Infarct Volume and Functional Outcomes,10.1002/ana.26219,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Mean difference; odds ratio;,Neither;,Yes,Yes,"NIHSS, mRS",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,6,9,Remote brain hemorrhage after IV thrombolysis: Role of preexisting lesions,10.1212/WNL.0000000000008874,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena t,,DC,6,10,"White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease",10.1002/mds.28510,Yes,,,cross-sectional,NA,UPDRS-III;,Parkinson's disease;,Beta coefficient(s) only;,Neither;,Yes,Yes,UPDRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,1,"2B, 2C, or 3 What Should Be the Angiographic Target for Endovascular Treatment in Ischemic Stroke?",10.1161/STROKEAHA.119.028891,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,2,Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson’s Disease,10.1002/mds.28805,Yes,,,cohort,NA,UPDRS-III;,Parkinson's disease;,Beta coefficient(s) only;,Neither;,Yes,Yes,UPDRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,3,"Association of prestroke metformin use, stroke severity, and thrombolysis outcome",10.1212/WNL.0000000000009951,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Comparison of values between exposure status with p-value;Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 3 top,mRS,No,Yes,No,NA;,,Yes,Figure 3 bottom,mRS,No,No,Yes,PS Matching;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,4,CHIT1 at Diagnosis Reflects Long-Term Multiple Sclerosis Disease Activity,10.1002/ana.25691,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,5,"Computed Tomography Angiography Spot  Sign, Hematoma Expansion, and Functional  Outcome in Spontaneous Cerebellar Intracerebral  Hemorrhage",10.1161/STROKEAHA.120.033297,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,6,Does Device Selection Impact Recanalization Rate and Neurological Outcome? An Analysis of the Save ChildS Study,10.1161/STROKEAHA.119.028221,Yes,,,cohort,NA,PedNIHSS;mRS;,Ischemic stroke;,Beta coefficient(s) only;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,7,Early clinical surrogates for outcome prediction after  stroke thrombectomy in daily clinical practice,10.1136/jnnp-2020-323742,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,AUC;ROC;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,8,Early Predictors of 9-Year Disability in Pediatric Multiple Sclerosis,10.1002/ana.26052,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Odds ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,9,Effect  of  Steady  and  Dynamic  Blood  Pressure  Parameters   During  Thrombectomy  According  to  the  Collateral  Status,10.1161/STROKEAHA.119.026769,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS,",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,10,Impact of Antiplatelet Therapy During Endovascular Therapy for Tandem Occlusions,10.1161/STROKEAHA.119.028231,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,11,Implementation of regional Acute Stroke Care Map increases thrombolysis rates for acute ischaemic stroke in Chinese urban area in only 3 months,10.1136/svn-2020-000332,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,12,Incidence and outcomes of intracerebral haemorrhage with mechanical compression hydrocephalus,10.1136/svn-2020-000401,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,No,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,13,Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm,10.1002/ana.25746,No,wrong outcome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,14,Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis,10.1136/jnnp-2019-322348,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,15,No Racial Disparity in Outcome Measures After Endovascular Treatment for Stroke in the Elderly,10.1161/STROKEAHA.120.033537,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,16,Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms,10.1161/STROKEAHA.120.032809,Yes,,,cohort,NA,mRS;Barthel Index;SIS-16;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,PedNIHSS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,17,Rescue of Neglect and Language Impairment After Stroke Thrombectomy,10.1161/STROKEAHA.121.034243,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,AUC;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,18,Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack,10.1136/svn-2020-000471,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,19,"Thrombectomy and Thrombolysis of Isolated Posterior Cerebral Artery Occlusion Cognitive, Visual, and Disability Outcomes",10.1161/STROKEAHA.119.026907,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus:,elena f,,DC,6,20,TMS for staging and predicting functional decline in frontotemporal dementia,10.1016/j.brs.2019.11.009,No,wrong outcome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,1,Age-Related Parkinsonian Signs in Microdeletion 22q11.3,10.1002/mds.28080,Yes,,,cross-sectional,NA,UPDRS-III;,Parkinson's disease;,Beta coefficient(s) only;,Neither;,No,Yes,UPDRS-III,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,2,Association of Seropositivity to Borrelia burgdorferi With the Risk of Neuropsychiatric Disorders and Functional Decline in Older Adults The Aging Multidisciplinary Investigation Study,10.1001/jamaneurol.2019.3292,Yes,,,cohort,NA,Lawton–Brody scale; Katz index;,Dementia;,Beta coefficient(s) only;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Consensus,emma,,DC,7,3,Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis A Real-world Case Series,10.1212/WNL.0000000000012449,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Odds ratio;,Neither;,No,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,4,Cladribine vs other drugs in MS Merging randomized trial with real-life data,10.1212/NXI.0000000000000878,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,5,"Comparison of outcome of patients with  acute minor ischaemic stroke treated  with intravenous t-PA, DAPT or aspirin",10.1136/svn-2019-000319,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,6,Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated Syndrome,10.1212/WNL.0000000000012726,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,7,"Functional Outcome, Recanalization, and Hemorrhage Rates After Large Vessel Occlusion Stroke Treated With Tenecteplase Before Thrombectomy",10.1212/WNL.0000000000012915,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,AUC;,No,No,NA,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,8,Intracranial pressure monitoring in the intensive care unit: An international prospective observational StudY on iNtrAcranial PreSsurE in intensive care (SYNAPSE-ICU).,10.1016/S1474-4422(21)00138-1,Yes,,,cohort,NA,GOSE;,Hemorrhagic stroke;TBI;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,9,Intravenous immunoglobulin treatment for mild  Guillain-Barré syndrome: an international  observational study,10.1136/jnnp-2020-325815,Yes,,,cohort,NA,GBS disability score; Rasch- Built  Overall Built Disability Score;,GBS;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,GDS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,10,Linear brain atrophy measures in multiple sclerosis  and clinically isolated syndromes: a 30-year follow-up,10.1136/jnnp-2020-325421,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Beta coefficient(s) only;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,11,MT in anticoagulated patients Direct oral anticoagulants versus vitamin K antagonists,10.1212/WNL.0000000000008873,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,Yes,Yes,Regression;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,12,Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability,10.1093/brain/awaa162,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Odds ratio;,AUC;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,13,Normal-Appearing  White  Matter  Integrity  Is  a    Predictor  of  Outcome  After  Ischemic  Stroke,10.1161/STROKEAHA.119.026886,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Beta coefficient(s) only;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,14,Novel selection paradigms for endovascular stroke  treatment in the extended time window,10.1136/jnnp-2020-325284,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,15,Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study,10.1136/jnnp-2019-321496,Yes,,,cohort,NA,GBS  disability  scale; medical research council ( MRC) sum score;,GBS;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,GDS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,16,Prognostic Value of Spreading Depolarizations in Patients With Severe Traumatic Brain Injury,10.1001/jamaneurol.2019.4476,Yes,,,cohort,NA,GOSE;,TBI;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2G,GOSE,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,17,Progressive Supranuclear Palsy and Statin Use,10.1002/mds.28038,No,wrong outcome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,18,Safety and Outcomes of Thrombectomy in Ischemic Stroke With vs Without IV Thrombolysis,10.1212/WNL.0000000000012327,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2A,mRS,No,Yes,No,NA;,,Yes,Figure 2B,mRS,Yes,No,Yes,PS Matching;,,Yes,Figure 2C,mRS,No,No,Yes,PS Matching;,,No,,,,,,,,,,,,,,,,,
,emma,,DC,7,19,Serum neurofilament light chain predicts long-term  prognosis in Guillain-Barré syndrome patients,10.1136/jnnp-2020-323899,Yes,,,cohort,NA,I-RODS; GDS;,Guillain-Barré;,Odds ratio;,ROC;AUC;,Yes,Yes,GDS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,7,20,Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis Data From 2 Different National Strategies,10.1001/jamaneurol.2021.2738,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,1,Analysis of the association of MPO and MMP-9 with stroke severity and outcome: Cohort study,10.1212/WNL.0000000000009179,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,2,Association of initial imaging modality and futile recanalization after thrombectomy,10.1212/WNL.0000000000010614,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,3,Blood Pressure Thresholds and Neurologic Outcomes After Endovascular Therapy for Acute Ischemic Stroke: An Analysis of Individual Patient Data From 3 Randomized Clinical Trials,10.1001/jamaneurol.2019.4838,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,4,Drip and ship for mechanical thrombectomy within the Neurovascular Network of Southwest Bavaria,10.1212/WNL.0000000000008753,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2A,mRS,No,Yes,No,NA;,,Yes,Figure 2B,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,5,Enterovirus Meningitis in Adults: A Prospective Nationwide Population-Based Cohort Study,10.1212/WNL.0000000000012294,Yes,,,cohort,NA,GOS;,Meningitis;,Risk ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,6,Favorable Venous Outflow Profiles Correlate With Favorable Tissue-Level Collaterals and Clinical Outcom,10.1161/STROKEAHA.120.032242,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,7,From Perviousness to Plaque Imaging in Acute Basilar Occlusions: The Impact of Underlying Stenosis and How to Detect It,10.1161/STROKEAHA.119.027472,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,No,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,8,Infarct Volume Before Hemicraniectomy in Large Middle Cerebral Artery Infarcts Poorly Predicts Catastrophic Outcome,10.1161/STROKEAHA.120.029920,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,ROC;AUC;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,9,Intraarterial Versus Intravenous Tirofiban as an Adjunct to Endovascular Thrombectomy for Acute Ischemic Stroke,10.1161/STROKEAHA.120.029994,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Comparison of values between exposure status with p-value;Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,10,Ischemic Stroke With Atrial Fibrillation: Characteristics and Time Trends 2006 to 2017 in the Dijon Stroke Registry,10.1161/STROKEAHA.120.030812,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 1,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,11,Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis,10.1212/WNL.0000000000009571,Yes,,,case-control,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,12,Predicting long-term outcomes in acute intracerebral haemorrhage using delayed prognostication scores,10.1136/svn-2020-000656,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,AUC;,AUC;ROC;,No,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,13,Predictors of Unexplained Early Neurological Deterioration After Endovascular Treatment for Acute Ischemic Stroke,10.1161/STROKEAHA.120.029494,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,14,Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures,10.1001/jamaneurol.2021.1437,Yes,,,cohort,NA,WIDEA-FS;,Seizures;,Mean difference;Odds ratio;,Neither;,Yes,Yes,WIDEA-FS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,15,Signs of Pulmonary Infection on Admission Chest Computed Tomography Are Associated With Pneumonia or Death in Patients With Acute Stroke,10.1161/STROKEAHA.120.028972,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,16,Smoking Paradox in Stroke Survivors?: Uncovering the Truth by Interpreting 2 Sets of Data,10.1161/STROKEAHA.119.027012,Yes,,,cohort,NA,mRS;,Stroke (all);,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,17,"Sphingosine-1-Phosphate, Motor Severity, and Progression in Parkinson's Disease (MARK-PD)",10.1002/mds.28652,Yes,,,cohort,NA,UPDRS-III;,Parkinson's disease;,Mean difference;,Neither;,Yes,Yes,UPDRS-III,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,18,Stroke Acute Management and Outcomes During the COVID-19 Outbreak: A Cohort Study From the Madrid Stroke Network,10.1161/STROKEAHA.120.031769,Yes,,,cohort,NA,mRS;,Stroke (all);,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 4a,mRS,No,Yes,No,NA;,,Yes,Figure 4bc,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,7,19,Treatment Restrictions and the Risk of Death in Patients With Ischemic Stroke or Intracerebral Hemorrhage,10.1161/STROKEAHA.120.029788,No,wrong outcome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,7,1,Recovery of Consciousness and Functional Outcome in Moderate and Severe Traumatic Brain Injury,10.1001/jamaneurol.2021.0084,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,7,2,Effect of thrombectomy on oedema progression and clinical outcome in patients with a poor collateral profile,10.1136/svn-2020-000570,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,7,3,"Pre-stroke disability assessed by modified Rankin Scale is associated with post-stroke adverse outcomes in hospital: a registry-based, prospective cohort study of acute stroke care in Surrey, United Kingdom",10.1161/STROKEAHA.119.027740,Yes,,,cohort,NA,NIHSS;,Stroke (all),Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,7,4,Endovascular Thrombectomy for Acute Ischemic Stroke Beyond 6 Hours From Onset,10.1161/STROKEAHA.119.027974,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,7,5,Stroke Etiology Modifies the Effect of Endovascular Treatment in Acute Stroke,10.1161/STROKEAHA.119.028383,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,7,6,Importance of Occlusion Site for Thrombectomy Technique in Stroke Comparison Between Aspiration and Stent Retriever,10.1161/STROKEAHA.120.030031,Yes,,,cohort,NA,NIHSS;mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,7,7,Hemorrhage Expansion After Pediatric Intracerebral Hemorrhage,10.1161/STROKEAHA.120.030592,Yes,,,cohort,NA,(KOSCHI) King’s Outcome Scale for Childhood Head Injury score;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,7,8,Delayed Neurological Improvement After Full Endovascular Reperfusion in Acute Anterior Circulation Ischemic Stroke,10.1161/STROKEAHA.120.032066,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,7,9,Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis,10.1212/WNL.0000000000012752,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,7,10,Thrombocytopenia and Clinical Outcomes in  Intracerebral Hemorrhage A Retrospective Multicenter Cohort Study,10.1161/STROKEAHA.120.031478,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,Yes,No,Yes,Stratified (select this if you previously indicated that the graph is stratified);PS Matching;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,1,Antidopaminergic treatment is associated with  reduced chorea and irritability but impaired cognition  in Huntington’s disease (Enroll-HD),10.1136/jnnp-2019-322038,Yes,,,cohort,NA,Unified  Huntington  Disease  Rating  Scale;,Huntington Disease;,Comparison of values between exposure status with p-value;,Neither;,Yes,Yes,UHDRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,2,Early Thrombectomy Protects the Internal  Capsule in Patients With Proximal Middle  Cerebral Artery Occlusion,10.1161/STROKEAHA.120.031977,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,3,Estimating the Effect of Early Treatment Initiation in Parkinson’s Disease Using Observational Data,10.1002/mds.28339,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,4,Frequency and Prognostic Significance of Clinical  Fluctuations Before Hospital Arrival in Stroke,10.1161/STROKEAHA.121.034124,Yes,,,cohort,NA,mRS;Barthel Index;Stroke Impact Scale 16;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,5,Impact of Delirium and Its Motor Subtypes on  Stroke Outcomes,10.1161/STROKEAHA.120.026425,Yes,,,cohort,NA,mRS;,Stroke (all);,Odds ratio;,Neither;,No,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,6,Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis,10.1212/WNL.0000000000011461,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,No,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,7,Mechanical Thrombectomy in Basilar Artery  Occlusion Clinical Outcomes Related to Posterior Circulation Collateral Score,10.1161/STROKEAHA.120.029861,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,AUC,No,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,8,Middle Cerebral Artery M2 Thrombectomy in the  STRATIS Registry,10.1161/STROKEAHA.120.033951,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,9,Mitochondrial DNA Copy Number as a Marker and Mediator of Stroke Prognosis Observational and Mendelian Randomization Analyses,10.1212/WNL.0000000000013165,Yes,,,case-control,NA,mRS;,Stroke (all);,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 2A,mRS,No,Yes,No,NA;,,Yes,Figure 3A,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,10,"Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective, Multicenter Cohort Study of Imaging Selection",10.1002/ana.25669,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS, NIHSS",Yes,Figure 5C,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,11,Phenome-wide examination of comorbidity burden and multiple sclerosis disease severity,10.1212/NXI.0000000000000864,Yes,,,cohort,NA,EDSS;Multiple Sclerosis Severity Score (MSSS);,Multiple sclerosis;,Odds ratio;,Neither;,Yes,Yes,"MSSS,",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,12,Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis,10.1001/jamaneurol.2021.1008,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,8,13,Fluid-Attenuated Inversion Recovery May Serve  As a Tissue Clock in Patients Treated With  Endovascular Thrombectomy,10.1161/STROKEAHA.120.033374,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 3,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,1,"A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up",10.1136/jnnp-2019-322614,Yes,,,cohort,NA,Scales  for  Outcomes  in  PD  (SCOPA);,Parkinson's disease;,Cohen's d;Risk difference; Comparison between exposure status with p-value,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,2,Association Between Time to Endovascular Therapy and Outcomes in Patients With Acute Basilar Artery Occlusion,10.1212/WNL.0000000000012858,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS, NIHSS",Yes,Figure 1A,mRS,No,Yes,No,NA;,,Yes,Figure 2B,mRS,No,Yes,No,NA;,,Yes,Figure 2c,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,
,elena T,,DC,8,3,Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event,10.1093/brain/awab043,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,4,Computed Tomography Perfusion After Thrombectomy An  Immediate  Surrogate  Marker  of  Outcome  After    Recanalization  in  Acute  Stroke,10.1161/STROKEAHA.120.029212,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS, NIHSS",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,5,CSF Neurofilament Light Chain Concentrations Predict Outcome in Bacterial Meningitis,10.1212/NXI.0000000000001123,Yes,,,cohort,NA,GOS;,Meningitis;,Odds ratio;,AUC;,Yes,Yes,GOS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,6,Electrographic Seizures and Outcome in Critically Ill Children,10.1212/WNL.0000000000012032,Yes,,,cohort,NA,GOS-E-Peds; PCPC;,Seizures;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,7,"Imaging markers of small vessel disease and brain frailty, and outcomes in acute stroke",10.1212/WNL.0000000000008881,Yes,,,cohort,NA,mRS;Barthel Index;,Stroke (all);,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,8,Independent Prognostic Value of MRproANP (Midregional Proatrial Natriuretic Peptide) Levels in Patients With Stroke Is Unaltered Over Time,10.1161/STROKEAHA.120.029333,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,9,Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study,10.1212/WNL.0000000000010135,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,,8,10,Longitudinal observational study investigating outcome measures for clinical trials in inclusion body myositis,10.1136/jnnp-2020-325141,Yes,,,cohort,NA,IBMFRS;,Inclusion body myositis (IBM);,Risk difference;,Neither;,Yes,Yes,IBMFRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,11,Long-term functional decline of spontaneous intracerebral haemorrhage survivors,10.1136/jnnp-2020-324741,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Hazard ratio;,Neither;,No,Yes,mRS,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,12,Long-term Functional Outcomes and Relapse of Anti-NMDA Receptor Encephalitis: A Cohort Study in Western China,10.1212/NXI.0000000000000958,Yes,,,cohort,NA,mRS;,Encephalitis;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 1 CDE,mRS,Yes,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,13,Mechanical Thrombectomy for Tandem Vertebrobasilar Stroke: Characteristics and Treatment Outcome,10.1161/STROKEAHA.120.029503,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,No,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,14,Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes,10.1136/jnnp-2020-325610,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,15,Preoperative REM Sleep Behavior Disorder and Subthalamic Nucleus Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery,10.1212/WNL.0000000000012862,Yes,,,cohort,NA,UPDRS-III;,Parkinson's disease;,Beta coefficient(s) only;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,16,Psychosis and longitudinal outcomes in Huntington disease: the COHORT Study,10.1136/jnnp-2019-320646,Yes,,,cohort,NA,UHDRS;,Huntington disease;,Beta coefficient(s) only;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,17,Safety and efficacy of oral antiplatelet for patients who had acute ischaemic stroke undergoing endovascular therapy,10.1136/svn-2020-000466,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;Hazard ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,18,"Stroke Outcome Prediction by Blood Pressure Variability, Heart Rate Variability, and Baroreflex Sensitivity",10.1161/STROKEAHA.119.027981,No,No,wrong publication type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,19,Time Matters: Adjusted Analysis of the Influence of Direct Transfer to Angiography-Suite Protocol in Functional Outcome,10.1161/STROKEAHA.119.028586,Yes,,,case-control,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS,NIHSS,",Yes,Figure 2 right top,mRS,No,Yes,No,NA;,,Yes,Figure 2 right middle/bottom,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,8,20,Ultra-Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral Hemorrhage,10.1002/ana.25793,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,1,Association of Spectral-Domain OCT With Long- term Disability Worsening in Multiple Sclerosis,10.1212/WNL.0000000000011788,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Odds ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,2,Clinical Course of Acute Ischemic Stroke Due  to Medium Vessel Occlusion With and Without  Intravenous Alteplase Treatment,10.1161/STROKEAHA.120.030227,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 3a,mRS,No,Yes,No,NA;,,Yes,Figure 3b,mRS,No,No,Yes,Regression;,,Yes,Figure 3c,mRS,No,Yes,No,NA;,,Yes,Figure 3d,mRS,No,No,Yes,Regression;,,No,,,,,,,,,
,emma,,DC,9,3,CO 2 combining power and outcomes in  patients with acute ischaemic stroke or  transient ischaemic attack,10.1136/svn-2020-000476,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,4,Early Infarct Growth Rate Correlation With  Endovascular Thrombectomy Clinical Outcomes Analysis From the SELECT Study,10.1161/STROKEAHA.120.030912,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,5,Effect of sex differences on prognosis of  intravenous thrombolysis: data from the  Thrombolysis Implementation and  Monitor of Acute Ischemic Stroke in  China (TIMS-China),10.1136/svn-2020-000351,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 1,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,6,Effectiveness of intravenous r-tPA  versus UK for acute ischaemic stroke: a  nationwide prospective Chinese  registry study,10.1136/svn-2020-000640,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio; Mean difference;,Neither;,Yes,No,NA,Yes,Figure 1,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,7,Endovascular Treatment Effect Diminishes With  Increasing Thrombus Perviousness Pooled Data From 7 Trials on Acute Ischemic Stroke,10.1161/STROKEAHA.120.033124,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,8,Fluid balance and outcome in critically ill patients with traumatic brain injury (CENTER-TBI and OzENTER- TBI),10.1016/S1474-4422(21)00162-9,Yes,,,cohort,NA,GOSE;,TBI;,Odds ratio;,Neither;,Yes,Yes,GOSE,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,9,Impact of Delirium on Outcomes After  Intracerebral Hemorrhage,10.1161/STROKEAHA.120.034023,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,AUC;,Yes,Yes,mRS,Yes,Figure 3,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,10,Impact of Sleep-Disordered Breathing on  Functional Outcomes in Ischemic Stroke A Cardiopulmonary Coupling Analysis,10.1161/STROKEAHA.119.028730,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,11,Late functional improvement and 5-year poststroke  outcomes: a population-based cohort study,10.1136/jnnp-2019-322365,Yes,,,cohort,NA,mRS;Barthel Index;,Ischemic stroke;,Hazard ratio;,Neither;,Yes,Yes,"mRS, BI",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,,9,12,Natural history of motor symptoms in Parkinson’s disease and the long-duration response to levodopa,10.1093/brain/awaa181,Yes,,,cross-sectional,NA,UPDRS-III;,Parkinson's disease;,Beta coefficient(s) only;,Neither;,Yes,Yes,UPDRS III,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,13,Prestroke Disability and Outcome After Thrombectomy for Emergent Anterior Circulation Large Vessel Occlusion Stroke,10.1212/WNL.0000000000012827,Yes,,,cohort,NA,UW-mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,14,Stroke Patients With Faster Core Growth Have  Greater Benefit From Endovascular Therapy,10.1161/STROKEAHA.121.034205,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 2,mRS,Yes,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,9,15,Unraveling the risk factors for spontaneous intracerebral hemorrhage among West Africans,10.1212/WNL.0000000000009056,Yes,,,case-control,NA,NIHSS;Stroke Levity Scale;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,1,Association of White Matter Lesions and Outcome After Endovascular Stroke Treatment,10.1212/WNL.0000000000010994,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,2,Blood Pressure During Endovascular Treatment Under Conscious Sedation or Local Anesthesia,10.1212/WNL.0000000000011006,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 4,mRS,No,Yes,No,NA,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,3,Combined Effect of Age and Baseline Alberta Stroke Program Early Computed Tomography Score on Post-Thrombectomy Clinical Outcomes in the MR CLEAN Registry,10.1161/STROKEAHA.120.031773,No,wrong publication type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,4,Direct to Angiography vs Repeated Imaging Approaches in Transferred Patients Undergoing Endovascular Thrombectomy,10.1001/jamaneurol.2021.1707,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 1A,mRS,No,Yes,No,NA;,,Yes,Figure 2BC,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,Yes,Figure 2D,mRS,No,No,Yes,PS Matching;,,No,,,,,,,,,,,,,,,,,
,elena T,,DC,9,5,Efficacy and safety of bridging thrombolysis initiated before transfer in a drip-and-ship stroke service,10.1136/svn-2021-001024,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,6,Endovascular Thrombectomy in Young Patients With Stroke: A MR CLEAN Registry Study,10.1161/STROKEAHA.120.034033,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,7,Endovascular treatment in older adults with acute ischemic stroke in the MR CLEAN Registry,10.1212/WNL.0000000000009764,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,8,General Anesthesia Versus Conscious Sedation and Local Anesthesia During Thrombectomy for Acute Ischemic Stroke,10.1161/STROKEAHA.120.028963,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,9,Impact of Strategy on Clinical Outcome in Large Vessel Occlusion Stroke Successfully Reperfused: ETIS Registry Results,10.1161/STROKEAHA.121.034422,No,wrong publication type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,10,Local Anesthesia Without Sedation During Thrombectomy for Anterior Circulation Stroke Is Associated With Worse Outcome,10.1161/STROKEAHA.120.029194,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Risk ratio;Mean difference;,Neither;,Yes,Yes,"mRS, NIHSS",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,11,"Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Endovascular Thrombectomy",10.1212/WNL.0000000000011566,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 1AB,mRS,No,Yes,No,NA;,,Yes,Figure 2B,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,12,Mismatch Profile Influences Outcome After Mechanical Thrombectomy,10.1161/STROKEAHA.120.031929,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2A,mRS,No,Yes,No,NA;,,Yes,Figure 2B,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,Yes,Figure 3A,mRS,No,Yes,No,NA;,,Yes,Figure 3B,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,
,elena T,,DC,9,13,Prevalence and Prognostic Significance of Malnutrition Risk in Patients With Acute Ischemic Stroke: Results From the Third China National Stroke Registry,10.1161/STROKEAHA.121.034366,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,14,The Incidence and Associated Factors of Early Neurological Deterioration After Thrombolysis: Results From SITS Registry,10.1161/STROKEAHA.119.028287,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,No,Yes,Regression;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,15,The role of infarct location in patients with DWI-ASPECTS 0-5 acute stroke treated with thrombectomy,10.1212/WNL.0000000000011096,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,16,The Stockholm Stroke Triage Project: Outcomes of Endovascular Thrombectomy Before and After Triage Implementation,10.1161/STROKEAHA.121.034195,Yes,,,cohort,NA,NIHSS;mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 3,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,17,Thrombectomy in Extensive Stroke May Not Be Beneficial and Is Associated With Increased Risk for Hemorrhage,10.1161/STROKEAHA.120.033101,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;Comparison of values between exposure status with p-value;,Neither;,Yes,Yes,mRS,Yes,Figure 1 top,mRS,No,No,Yes,PS Matching;,,Yes,Figure 1 bottom,mRS,Yes,No,Yes,Stratified (select this if you previously indicated that the graph is stratified);PS Matching;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,,9,18,Thrombectomy vs medical management in low NIHSS acute anterior circulation stroke,10.1212/WNL.0000000000010955,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,Yes,No,NA;,,Yes,Figure 3,mRS,No,No,Yes,PS Matching;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,19,Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment: The INTERRSeCT Study,10.1161/STROKEAHA.120.029292,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS, NIHSS",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,9,20,National Institutes of Health Stroke Scale An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke,10.1161/STROKEAHA.119.026791,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,1,Admission Blood Pressure in Relation to Clinical Outcomes and Successful Reperfusion After Endovascular Stroke Treatment,10.1161/STROKEAHA.120.029907,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS, NIHSS",Yes,Figure 1,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,,9,2,Anesthetic management during endovascular treatment of acute ischemic stroke in the MR CLEAN Registry,10.1212/WNL.0000000000008674,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,3,Association Between Immigration Status and Acute Stroke Care: A Retrospective Study,10.1161/STROKEAHA.119.027791,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;Risk ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,4,Association Between Low Blood Pressure and Clinical Outcomes in Patients With Acute Ischemic Stroke,10.1161/STROKEAHA.119.027336,No,wrong publication type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,5,Blood Pressure After Endovascular Thrombectomy Modeling for Outcomes Based on Recanalization Status,10.1161/STROKEAHA.119.026914,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"NIHSS, mRS",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,6,Blood Pressure Trajectory Groups and Outcome After Endovascular Thrombectomy: A Multicenter Study,10.1161/STROKEAHA.121.034408,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS, NIHSS",Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,7,Brain imaging abnormalities and outcome after acute  ischaemic stroke: the ENCHANTED trial,10.1136/jnnp-2020-323015,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,8,Bridging versus direct endovascular therapy in basilar artery occlusion,10.1136/jnnp-2020-325328,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 3,mRS,No,Yes,No,NA;,,Yes,Figure 4,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,9,Clinical and Neuroimaging Outcomes of Direct Thrombectomy vs Bridging Therapy in Large Vessel Occlusion Analysis of the SELECT Cohort Study,10.1212/WNL.0000000000012063,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS,NIHSS,",Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,10,Good Clinical Outcome Decreases With Number of Retrieval Attempts in Stroke Thrombectomy,10.1161/STROKEAHA.120.029830,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 1B,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,11,Increased Serum Complement C3 Levels Are Associated With Adverse Clinical Outcomes After Ischemic Stroke,10.1161/STROKEAHA.120.031715,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,12,Intended Bridging Therapy or Intravenous Thrombolysis Alone in Minor Stroke With Basilar Artery Occlusion,10.1161/STROKEAHA.120.030992,No,wrong publication type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,13,Lack of Reperfusion Rather Than Number of  Passes Defines Futility in Stroke Thrombectomy A Matched Case-Control Study,10.1161/STROKEAHA.120.033539,Yes,,,case-control,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure top,mRS,No,Yes,No,NA;,,Yes,Figure bottom,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,14,Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis,10.1093/brain/awaa340,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,15,Noncontrast Computed Tomography e-Stroke Infarct Volume Is Similar to RAPID Computed Tomography Perfusion in Estimating Postreperfusion Infarct Volumes,10.1161/STROKEAHA.120.031651,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,16,Prevalence and Outcome of Potential Candidates  for Left Atrial Appendage Closure After Stroke  With Atrial Fibrillation WATCH-AF Registry,10.1161/STROKEAHA.120.029267,Yes,,,cohort,NA,mRS;,Stroke (all);,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,17,Race/ethnicity influences outcomes in young adults with supratentorial intracerebral hemorrhage,10.1212/WNL.0000000000008930,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,18,"Safety and Efficacy of Intra-arterial Urokinase After Failed, Unsuccessful, or Incomplete Mechanical Thrombectomy in Anterior Circulation Large-Vessel Occlusion Stroke",10.1001/jamaneurol.2019.4192,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS, NIHSS",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,19,Smoking Status and Functional Outcomes After Acute Ischemic Stroke,10.1161/STROKEAHA.119.027230,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,DC,9,20,Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom,10.1212/NXI.0000000000001008,No,no adjusted effect estimate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,1,Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry,10.1001/jamaneurol.2020.0156,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 1A,mRS,No,Yes,No,NA;,,Yes,Figure 1B,mRS,No,No,Yes,PS Matching;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,2,Association Between Prehospital Tranexamic Acid Administration and Outcomes of Severe Traumatic Brain Injury,10.1001/jamaneurol.2020.4596,Yes,,,cohort,NA,GOS;,TBI;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,,10,3,Association of Interleukin-6 Levels and Futile Reperfusion After Mechanical Thrombectomy,10.1212/WNL.0000000000011268,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,AUC;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,4,Association of timing of gabapentinoid use with motor recovery after spinal cord injury,10.1212/WNL.0000000000010950,Yes,,,cohort,NA,ISNCSCI; SCIM 3;,Spinal Cord Injury;,Beta coefficient(s) only;,Neither;,Yes,Yes,"ISNCSCI motor score, SCIM",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,6,Characteristics and Outcomes in Patients With  COVID-19 and Acute Ischemic Stroke The Global COVID-19 Stroke Registry,10.1161/STROKEAHA.120.031208,No,wrong publication type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,7,Endovascular  Treatment  for  Acute  Ischemic    Stroke  in  Patients  on  Oral  Anticoagulants Results  From  the  MR  CLEAN  Registry,10.1161/STROKEAHA.119.028675,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,8,Endovascular Therapy of Anterior Circulation  Tandem Occlusions Pooled Analysis From the TITAN and ETIS Registries,10.1161/STROKEAHA.120.033032,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,9,Glucose-6-phosphate dehydrogenase deficiency and stroke outcomes,10.1212/WNL.0000000000010245,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;Risk difference;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,No,Yes,Regression;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,10,High Admission Glucose Is Associated With  Poor Outcome After Endovascular Treatment for  Ischemic Stroke,10.1161/STROKEAHA.120.029944,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS, NIHSS",Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,11,Outcomes of Large Vessel Occlusion Stroke in  Patients Aged ≥90 Years,10.1161/STROKEAHA.120.031386,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,Yes,Figure 3,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,12,Perfusion Imaging and Clinical Outcome in Acute Ischemic Stroke with Large Core,10.1002/ana.26152,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 4A,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,Yes,Figure 4B,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,13,Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation,10.1002/ana.25917,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 3,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,14,Rapid Assessment of Blood Pressure Variability  and Outcome After Successful Thrombectomy,10.1161/STROKEAHA.121.034291,No,wrong publication type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,15,Relationship between blood pressure and outcome changes over time in acute ischemic stroke,10.1212/WNL.0000000000010203,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,16,Renal impairment on clinical outcomes following endovascular recanalization,10.1212/WNL.0000000000008748,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,Yes,No,NA;,,Yes,Figure 3,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,17,Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis Real-world Evidence From the GENERATE Registry,10.1212/NXI.0000000000001088,Yes,,,cohort,NA,mRS;,encephalitis;,Risk ratio;,Neither;,Yes,No,NA,Yes,Figure 3Ga,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,Yes,Figure 3Gb,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,Yes,Figure 3Gc,mRS,Yes,Yes,No,NA;,,Yes,Figure 3Gd,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,
,emma,,DC,10,18,"Thrombectomy Complications in Large Vessel  Occlusions: Incidence, Predictors, and Clinical  Impact in the ETIS Registry",10.1161/STROKEAHA.121.034865,No,wrong publication type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,19,Thrombectomy Versus Combined Thrombolysis  and Thrombectomy in Patients With Acute Stroke A Matched-Control Study,10.1161/STROKEAHA.120.031599,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;Comparison of values between exposure status with p-value; Mean difference,Neither;,Yes,Yes,mRS,Yes,Figure 2,mRS,No,No,Yes,PS Matching;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,emma,,DC,10,20,β-Cell Function and Clinical Outcome in  Nondiabetic Patients With Acute Ischemic Stroke,10.1161/STROKEAHA.120.031392,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS, NIHSS",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,10,1,Artery occlusion independently predicts unfavorable outcome in cervical artery dissection,10.1212/WNL.0000000000008654,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,,10,2,Aspiration Versus Stent Retriever Thrombectomy  for Posterior Circulation Stroke,10.1161/STROKEAHA.121.034926,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,,10,3,Association between Computed Tomographic Biomarkers of Cerebral Small Vessel Diseases and Long-Term Outcome after Spontaneous Intracerebral Hemorrhage,10.1002/ana.25949,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,10,4,Bridging Therapy or IV Thrombolysis in Minor Stroke with Large Vessel Occlusion,10.1002/ana.25756,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,10,5,Cortical Microinfarcts Associated With Worse  Outcomes in Patients With Acute Ischemic Stroke  Receiving Endovascular Treatment,10.1161/STROKEAHA.120.030895,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 2A,mRS,No,Yes,No,NA;,,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,10,6,Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study,10.1136/jnnp-2020-324869,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10,7,Endovascular treatment in anterior circulation stroke beyond 6.5 hours after onset or time last seen well: results from the MR CLEAN Registry,10.1136/svn-2020-000803,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,,10,8,Epidemiology of Dementia and Alzheimer Disease in Individuals With Down Syndrome,10.1001/jamaneurol.2019.3666,No,wrong publication type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,10,9,Intraluminal Thrombus and Outcomes of Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Treatment,10.1161/STROKEAHA.120.032876,No,wrong publication type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,10,10,Microemboli After Successful Thrombectomy Do Not Affect Outcome but Predict New Embolic Events,10.1161/STROKEAHA.119.025856,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,10,11,Neurologic deterioration in patients with acute ischemic stroke or transient ischemic attack,10.1212/WNL.0000000000010603,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Risk ratio;Odds ratio;,Neither;,Yes,Yes,NIHSS,Yes,Figure 4,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10,12,Perfusion Imaging Predicts Favorable Outcomes after Basilar Artery Thrombectomy,10.1002/ana.26272,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2A,mRS,No,Yes,No,NA;,,Yes,Figure 2B,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,Yes,Figure 2C,mRS,No,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,
,elena T,,,10,13,Predictors of Functional Outcome After   Thrombectomy in Patients With Prestroke  Disability in Clinical Practice,10.1161/STROKEAHA.121.034960,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,10,14,Prevalence and Outcomes of Medium Vessel Occlusions With Discrepant Infarct Patterns,10.1161/STROKEAHA.120.030041,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,10,15,Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients,10.1161/STROKEAHA.120.033152,Yes,,,cohort,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,,10,16,Role of Apparent Diffusion Coefficient Gradient Within Diffusion Lesions in Outcomes of Large Stroke After Thrombectomy,10.1161/STROKEAHA.121.035615,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,AUC;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,,10,17,Short- and long-term outcome of patients with aneurysmal subarachnoid hemorrhage,10.1212/WNL.0000000000010618,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,DC,10,18,Stroke Imaging Selection Modality and Endovascular Therapy Outcomes in the Early and Extended Time Windows,10.1161/STROKEAHA.120.031685,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2,mRS,Yes,Yes,No,Stratified (select this if you previously indicated that the graph is stratified);,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,,10,19,"The SITS Open Study: A Prospective, Open Label Blinded Evaluation Study of Thrombectomy in Clinical Practice",10.1161/STROKEAHA.120.031031,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,No,NA,Yes,Figure 2A,mRS,No,No,Yes,PS Matching;,,Yes,Figure 2B,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,
,elena T,,,10,20,Time from I.V. Thrombolysis to Thrombectomy and Outcome in Acute Ischemic Stroke,10.1002/ana.25978,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,"mRS, NIHSS",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,,10,1,Association of Time of Day When Endovascular Therapy for Stroke Starts and Functional Outcome,10.1212/WNL.0000000000011449,Yes,,,cohort,NA,UW-mRS;mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,UW-mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,,10,2,Automated Annotation of Epileptiform Burden and Its Association with Outcomes,10.1002/ana.26161,No,wrong study design,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,,10,3,Blood Pressure in the First 6 Hours Following Endovascular Treatment for Ischemic Stroke Is Associated With Outcome,10.1161/STROKEAHA.120.033657,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,,10,4,Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis,10.1093/brain/awaa251,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,,10,5,Endovascular Treatment After Stroke Due to Large Vessel Occlusion for Patients Presenting Very Late From Time Last Known Well,10.1001/jamaneurol.2020.2804,Yes,,,case-control,NA,mRS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 1,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,,10,6,Endovascular Treatment for Acute Stroke in Cerebral Amyloid Angiopathy,10.1161/STROKEAHA.120.033014,No,wrong publication type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,,10,7,Hematoma expansion is more frequent in deep than lobar intracerebral hemorrhage,10.1212/WNL.0000000000010990,Yes,,,cohort,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,AUC;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10,8,Influence of Preexisting Cognitive Impairment on Clinical Severity of Ischemic Stroke,10.1161/STROKEAHA.119.028845,Yes,,,cohort,NA,NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,NIHSS,Yes,Figure 1,NIHSS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,,10,9,One-Year Outcome After Endovascular Treatment for Acute Basilar Artery Occlusion,10.1161/STROKEAHA.120.033658,No,wrong publication type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10,10,Pediatric Multiple Sclerosis Severity Score in a large US cohort,10.1212/WNL.0000000000010414,Yes,,,cohort,NA,Ped-MSSS;EDSS;,Multiple sclerosis;,Beta coefficient(s) only;,Neither;,Yes,Yes,"EDSS, PedMSSS",No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,,10,11,Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome,10.1212/NXI.0000000000001047,Yes,,,cohort,NA,EDSS;,Multiple sclerosis;,Hazard ratio;,Neither;,Yes,Yes,EDSS,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,,10,12,Selective Serotonin Reuptake Inhibitors and Intracerebral Hemorrhage Risk and Outcome,10.1161/STROKEAHA.119.028406,Yes,,,case-control,NA,mRS;,Hemorrhagic stroke;,Odds ratio;,Neither;,Yes,No,NA,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,elena F,,,10,13,White Matter Lesions and Outcomes After Endovascular Treatment for Acute Ischemic Stroke,10.1161/STROKEAHA.120.033334,Yes,,,cohort,NA,mRS;NIHSS;,Ischemic stroke;,Odds ratio;,Neither;,Yes,Yes,mRS,Yes,Figure 2,mRS,No,Yes,No,NA;,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,